In a patient with subdural hematoma requiring rapid intracranial pressure reduction or treatment of symptomatic hyponatremia, how should 3% hypertonic saline be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

3% Hypertonic Saline Administration in Subdural Hematoma

In patients with subdural hematoma requiring intracranial pressure reduction, administer 3% hypertonic saline as 100 mL boluses over 10 minutes, repeatable up to three times at 10-minute intervals, with a target sodium correction not exceeding 8 mmol/L in any 24-hour period. 1

Indications for 3% Hypertonic Saline in SDH

Use 3% hypertonic saline for:

  • Elevated intracranial pressure (ICP) – Hypertonic saline effectively reduces ICP in traumatic brain injury including subdural hematoma, with evidence showing improved cerebral perfusion pressure and reduced duration of intracranial hypertension 1, 2
  • Severe symptomatic hyponatremia (sodium <120 mmol/L with neurological symptoms such as altered mental status, seizures, or coma) – This requires immediate intervention regardless of the presence of SDH 1, 3, 4
  • Impending herniation – Patients with signs of transtentorial herniation benefit from urgent hyperosmolar therapy 1, 5

Dosing Protocol

Bolus administration:

  • Give 100 mL of 3% NaCl intravenously over 10 minutes 1, 3
  • May repeat up to three times at 10-minute intervals for severe symptoms or refractory ICP elevation 1, 3
  • For ICP management specifically, bolus doses of 250 mL have been used in studies, though 100 mL boluses provide more controlled correction 1

Continuous infusion (alternative approach):

  • 3% hypertonic saline continuous infusion may be used for sustained ICP control, particularly in pediatric TBI or when prolonged management is anticipated 1
  • Target serum sodium of 145-155 mmol/L has been used safely in some head injury protocols, though this represents controlled hypernatremia requiring careful monitoring 1, 3

Critical Correction Rate Limits

Never exceed 8 mmol/L sodium increase in any 24-hour period to prevent osmotic demyelination syndrome, even in acute settings 1, 3, 6, 7

For severe symptomatic hyponatremia concurrent with SDH:

  • Initial target: 6 mmol/L increase over 6 hours or until severe symptoms resolve 3, 6, 4
  • After initial 6 mmol/L correction, only 2 mmol/L additional correction is permitted in the remaining 18 hours to stay within the 8 mmol/L/24-hour limit 3, 6

High-risk patients require even slower correction (4-6 mmol/L per day maximum):

  • Advanced liver disease 1, 3, 6, 7
  • Chronic alcoholism 3, 6, 7
  • Malnutrition 3, 6, 7
  • Chronic hyponatremia (>48 hours duration) 3, 6, 7

Monitoring Requirements

Serum sodium monitoring:

  • Every 2 hours during initial correction phase for severe symptomatic hyponatremia 3, 6, 4
  • Every 4-6 hours after symptom resolution or for ongoing ICP management 1, 3, 6
  • Re-check within 6 hours after each bolus to guide further therapy 1, 3

Clinical monitoring:

  • Neurological examination – Glasgow Coma Scale, pupillary response, motor function 2, 4, 5
  • ICP monitoring (if device in place) – Target ICP <20 mmHg 1, 2
  • Cerebral perfusion pressure – Maintain CPP >60 mmHg 1, 8

Special Considerations in SDH

Surgical decompression patients:

  • Higher doses of hypertonic saline (>8.0 mEq/kg sodium over 5 days) are associated with improved survival in surgically decompressed SDH patients (7.5% mortality vs 38.9% with lower doses) 2
  • ≥1400 mEq total sodium administration correlates with better neurological outcomes at 3 months (76.9% following commands vs 50.0% with lower doses) 2
  • Continue 3% saline infusion perioperatively when initiated prehospital or in emergency department 5

Combination with surgical evacuation:

  • Hypertonic saline as bridge to surgery – Early preoperative administration improves cerebral perfusion pressure and may optimize conditions for surgical intervention 8
  • Combined treatment (HTS + surgical evacuation) shows slightly better outcomes than surgery alone in animal models, though both are effective 8

Transition and Maintenance

After initial stabilization:

  • Switch to isotonic maintenance fluids (0.9% NaCl) once severe symptoms resolve and sodium reaches 120-125 mmol/L 3, 4
  • Avoid hypotonic solutions (0.45% saline, lactated Ringer's, D5W) as they can worsen cerebral edema 3, 4
  • For sustained ICP control, may continue 3% infusion for 24-48 hours with intensive monitoring 2, 5

Management of Overcorrection

If sodium rises >8 mmol/L in 24 hours:

  • Immediately discontinue hypertonic saline 3, 6, 7
  • Administer D5W (5% dextrose in water) to lower sodium 3, 6, 7
  • Consider desmopressin to slow or reverse rapid sodium rise 3, 6, 7
  • Target: bring total 24-hour correction back to ≤8 mmol/L from baseline 3, 6

Hypernatremia Correction After Prolonged HTS Use

If iatrogenic hypernatremia develops from prolonged 3% saline therapy:

  • Do not leave hypernatremia uncorrected – The brain adapts to elevated sodium within 48-72 hours, and failure to correct creates risk of rebound ICP elevation when therapy is discontinued 9
  • Maximum correction rate: 10-15 mmol/L per 24 hours using hypotonic fluids (D5W or 0.45% NaCl) 9
  • Target rate: 0.4 mmol/L/hour to prevent osmotic demyelination during correction 9
  • Monitor sodium every 4-6 hours during correction phase 9

Common Pitfalls to Avoid

  • Never use fluid restriction in SDH patients with hyponatremia – This can worsen cerebral perfusion and is contraindicated in neurosurgical patients at risk for vasospasm 1, 3, 4
  • Never exceed 8 mmol/L correction in 24 hours – Osmotic demyelination syndrome can occur 2-7 days after rapid correction with devastating neurological consequences 3, 6, 7
  • Never continue uncorrected hypernatremia after prolonged HTS therapy – Brain adaptation means rebound ICP elevation risk regardless of iatrogenic cause 9
  • Never use lactated Ringer's or other hypotonic solutions in acute SDH management – These worsen cerebral edema 3, 4
  • Never delay treatment while awaiting ADH or natriuretic peptide levels – These tests do not alter acute management and cause harmful delays 3, 4

Integration Across Care Continuum

Prehospital to hospital transition:

  • Continue prehospital-initiated 3% saline upon trauma center arrival – Integrated protocols improve outcomes 5
  • Communicate total sodium administered to receiving team for accurate 24-hour correction tracking 2, 5
  • Maintain consistent monitoring intervals across care transitions 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diagnosis and treatment of hyponatraemia in neurosurgical patients.

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2016

Guideline

Correction of Sodium and Osmolality

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypernatremia Correction in Patients Treated with Hypertonic Saline Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dose of hypertonic saline (hypertonic saline solution) for a patient with subdural hematoma (SDH) and elevated intracranial pressure (ICP)?
What is the recommended dose of hypertonic 3% saline (hypertonic saline solution) for an adult patient with a subdural hematoma (SDH)?
What is the appropriate timeframe to wait before seeking medical attention for a 24-year-old female experiencing abdominal pain, nausea, vomiting, and dehydration after alcohol consumption while taking Vyvanse (lisdexamfetamine)?
What is the recommended treatment for severe symptomatic hyponatremia using 3% (three percent) saline?
What is the recommended way to correct symptomatic hyponatremia with hypertonic 3% sodium chloride in a patient with a subdural hematoma?
How do acebrophylline and doxophylline differ in chemical structure, pharmacologic actions, dosing, and safety profile?
What medication regimen is recommended for acute insomnia in an adult inpatient, including first‑line non‑benzodiazepine hypnotics, dosing, and adjustments for age, weight, liver disease, and fall risk?
In an adult inpatient with acute insomnia and low fall risk, what melatonin dosing is recommended, including adjustments for elderly patients and hepatic impairment, and is ramelteon an appropriate alternative?
How should I prepare the norepinephrine (NE) dilution for an adult patient in circulatory shock?
In a 31‑year‑old man with left thalamic intracerebral hemorrhage, string‑and‑bead appearance of the left posterior cerebral artery on digital subtraction angiography, and low adenosine deaminase‑2 activity, what diagnosis is suggested?
Can a food foreign body lodged in the neck or airway be visualized on a routine chest X‑ray?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.